The purpose of this study is to determine the toxicity and tolerance of Adriamycin/Bleomycin/Vincristine (ABV) cytotoxic chemotherapy and either ddI or ddC (investigational antiretroviral agents) when given together in patients with advanced cutaneous or visceral Kaposi's sarcoma.
Showing the most recent 10 out of 869 publications